Alimera Sciences, Inc. Logo Image

Alimera Sciences, Inc.

Alimera Sciences, Inc. Banner Image

Most Recent Annual Report

2018 Annual Report and Form 10K

Alimera Sciences, Inc.

Annual
Report

Alimera Sciences, Inc. has reached its limit for free report views.

Alimera Sciences, Inc. does not currently have any hardcopy reports on AnnualReports.com. Click the button below to request a report when hardcopies become available.

Archived Annual Reports

About Alimera Sciences, Inc.

51-200 Employees
Based in Alpharetta, Georgia

Alimera, founded in June 2003, is a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals. Alimera is presently focused on diseases affecting the back of the eye, or retina, because these diseases are not well treated with current therapies and will affect millions of people in aging populations. Alimera's commitment to retina specialists and their patients is manifest in its product and in its development portfolio designed to treat early- and late-stage diseases.

Ticker:
ALIM
Exchange:
NASDAQ (See More NASDAQ Companies)
Industry:
Drug Manufacturers - Major (See More Drug Manufacturers - Major Companies)
Sector:
Healthcare (See More Healthcare Companies)

Looking for Other Annual Reports?

Search by company name or ticker symbol